SCI & TECH● LOWSep 8 · Sep 8, 2026, 10:57 AM
Roivant climbs on mid-stage trial win for lung disease candidate
Seeking Alpha Tech · global
Roivant's stock rose following a successful mid-stage clinical trial for its lung disease candidate. This positive trial outcome represents a potential advancement in medical treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH49m agoCan LTM pivot towards shorter - tenure AI deals accelerate revenue growth in H2 ? livemint.com · IndiaSCI & TECH49m agoAI levels the field ; human judgment will decide who wins , say leaders at IIM Sambalpur Delhi Centre during its Annual Conclave - India Education | Latest Education News | Global Educational Newsindiaeducationdiary.in · IndiaSCI & TECH1h agoArchaeologists are uncovering the meaning of a unique rock art siteNew ScientistSCI & TECH1h agoTelix and Ekalia to Collaborate on Astatine - 211 Production in the U . S . australiannews.net · Australia